Hanmi Science (KO:008930) — Market Cap & Net Worth
Market Cap & Net Worth: Hanmi Science (008930)
Hanmi Science (KO:008930) has a market capitalization of $1.73 Billion (₩2.55 Trillion) as of May 2, 2026. Listed on the KO stock exchange, this Korea-based company holds position #6806 globally and #187 in its home market, demonstrating a -2.46% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Hanmi Science's stock price ₩37700.00 by its total outstanding shares 67713706 (67.71 Million). Analyse cash flow conversion of Hanmi Science to see how efficiently the company converts income to cash.
Hanmi Science Market Cap History: 2015 to 2026
Hanmi Science's market capitalization history from 2015 to 2026. Data shows change from $4.73 Billion to $1.73 Billion (-8.45% CAGR).
Hanmi Science Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Hanmi Science's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Hanmi Science's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.01x
Hanmi Science's market cap is 0.01 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $2.26 Billion | $665.28 Billion | $7.94 Billion | 0.00x | 0.28x |
| 2017 | $4.48 Billion | $652.32 Billion | $30.07 Billion | 0.01x | 0.15x |
| 2018 | $3.26 Billion | $708.00 Billion | $18.02 Billion | 0.00x | 0.18x |
| 2019 | $1.62 Billion | $816.62 Billion | $30.74 Billion | 0.00x | 0.05x |
| 2020 | $3.30 Billion | $857.38 Billion | $22.60 Billion | 0.00x | 0.15x |
| 2021 | $2.40 Billion | $950.16 Billion | $42.94 Billion | 0.00x | 0.06x |
| 2022 | $1.48 Billion | $1.05 Trillion | $69.21 Billion | 0.00x | 0.02x |
| 2023 | $1.79 Billion | $1.25 Trillion | $115.12 Billion | 0.00x | 0.02x |
| 2024 | $1.35 Billion | $1.28 Trillion | $59.42 Billion | 0.00x | 0.02x |
| 2025 | $1.66 Billion | $1.36 Trillion | $118.37 Billion | 0.00x | 0.01x |
Competitor Companies of 008930 by Market Capitalization
Companies near Hanmi Science in the global market cap rankings as of May 2, 2026.
Key companies related to Hanmi Science by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #246 globally with a market cap of $99.71 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #441 globally with a market cap of $59.14 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #570 globally with a market cap of $45.94 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1111 globally with a market cap of $22.95 Billion USD ( AU$32.44 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #246 | McKesson Corporation | NYSE:MCK | $99.71 Billion | $814.02 |
| #441 | Cencora Inc. | NYSE:COR | $59.14 Billion | $304.00 |
| #570 | Cardinal Health Inc | NYSE:CAH | $45.94 Billion | $195.24 |
| #1111 | Sigma Healthcare Ltd | AU:SIG | $22.95 Billion | AU$2.81 |
Hanmi Science Historical Marketcap From 2015 to 2026
Between 2015 and today, Hanmi Science's market cap moved from $4.73 Billion to $ 1.73 Billion, with a yearly change of -8.45%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩1.73 Billion | +4.00% |
| 2025 | ₩1.66 Billion | +23.09% |
| 2024 | ₩1.35 Billion | -24.63% |
| 2023 | ₩1.79 Billion | +21.44% |
| 2022 | ₩1.48 Billion | -38.58% |
| 2021 | ₩2.40 Billion | -27.10% |
| 2020 | ₩3.30 Billion | +103.00% |
| 2019 | ₩1.62 Billion | -50.23% |
| 2018 | ₩3.26 Billion | -27.21% |
| 2017 | ₩4.48 Billion | +98.65% |
| 2016 | ₩2.26 Billion | -52.30% |
| 2015 | ₩4.73 Billion | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Hanmi Science was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.73 Billion USD |
| MoneyControl | $1.73 Billion USD |
| MarketWatch | $1.73 Billion USD |
| marketcap.company | $1.73 Billion USD |
| Reuters | $1.73 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Hanmi Science
Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult's bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition… Read more